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Rosin, a natural resin, was used as a hydrophobic matrix material for the controlled release, using 
diltiazem HCl as model drug. Matrix tablets were prepared by direct compression method using rosin 
as matrix forming material in different proportions and with different diluent combinations. The 
tablets prepared were flat faced, retained their shape throughout. The method of preparation of matrix 
system and its concentration were found to have pronounced effect on the release of diltiazem HCl. 
The release was found to follow both the first order kinetics and fickian diffusion. The drug delivery 
was analyzed using the paddle method according to USP XXIII. All the studies were done in 
phosphate buffer pH 7.4. The matrix tablets were evaluated for its thickness, hardness, friability, 
weight variation, drug content and invitro release studies. The results suggest that the rosin is useful in 
developing sustained release matrix tablets,  prolong release of water soluble drug  for up to 24h. 
Rosin thus promises considerable utility in the development of oral sustained release drug delivery 
systems. 
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INTRODUCTION 
Oral sustained release systems continue to dominate the market despite the advancements made in 
other drug delivery systems in order to increase the clinical efficacy and patient compliance. From a 
practical pharmaceutical view point, numerous types of polymers are currently employed to control 
the drug release from the pharmaceutical dosage form. Oral sustained release systems are mainly 
grouped into three types, e.g. reservoir, monolithic and matrix types1,2. Among these hydrophilic 
matrix tablets are preferred in the formulations since most display good compression characteristics, 
even when directly compressed and have adequate swelling properties that lead to a rapid formation of 
external layer, allowing drug release modification.  
Various natural gums and mucilages have been examined as polymers for sustained drug release, in 
the last few decades3,4. The physical and structural properties and the drug release mechanisms and 
kinetics of these sustained release preparations determine the in vivo performance of these dosage 
forms.  Rosin and rosin-based polymers have drug delivery applications achieving sustained/controlled 
release profiles.  
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The use of natural polymers and their semi-synthetic derivatives in drug delivery continues to be an 
area of active research despite the advent of synthetic polymers. Natural polymers remain attractive 
primarily because they are inexpensive, readily available, capable of multitude of chemical 
modifications and potentially degradable and compatible due to their origin. One such biopolymer is 
rosin. Rosin and its derivatives have been pharmaceutically evaluated as microencapsulating 
materials5-7, as anhydrous binding agents in tablets8,9, as film coating materials10,11 as transdermal drug 
delivery12.   
They are also used in chewing gum bases and cosmetics. Rosin a natural product, is used as a matrix 
forming polymer in the present work. Rosin, is a solid resin obtained from Pinus palustris Miller and 
from other species of Pinus linnae. It is composed of approximately 90% rosin acids. The rosin acids 
are monocarboxylic and have a typical molecular formula C20H30O2. The prominent ones include 
abietic acid with conjugated double bonds and pimaric acid with non-conjugated double bonds. The 
rosin acid molecules possess two chemically reactive centers, the double bonds and the carboxyl 
group. Being of natural origin, rosin and its derivatives are expected to be biodegradable and 
biocompatible13,14. They are also widely used for their film forming properties in paints, varnishes, as a 
stiffening agent, and as adhesive (used in plasters, cerates, ointments and water proofing etc.,).  
 Diltiazem is a calcium channel blocker widely used for its peripheral and vasodilator 
properties. It is also used for lowering blood pressure and has some effect on cardiac induction. It is 
given as oral dosage form in the treatment of angina pectoris and the management of hypertension. Its 
short biological half life (3-5 h), high aqueous solubility, and frequent administration (usually three to 
four times a day) make it a potential candidate for sustained release preparations15,16.  
 
MATERIALS AND METHODS 
Materials 
Rosin was purchased from Yucca Enterprises, Dombiuli, Thane, Diltiazem HCl was obtained as gift 
sample from Torrent Pharmaceuticals Ltd, Gujarat, India. Other chemicals lactose, talc, magnesium 
stearate, microcrystalline cellulose, dicalcium phosphate and mannitol (S.D. Fine Chemicals, Mumbai, 
India) were obtained commercially and used as such.                                                    
Method 
Diltiazem hydrochloride calibration curve 
 Calibration curve of Diltiazem HCl was prepared using buffer pH 7.4 in the concentration 
range of 1 – 15 µg/ml.  The drug was analyzed spectrophotometrically (UV 1601 Shimadzu, Japan) at 
237 nm (regression coefficient r2 = 0.9994 in buffer pH 7.4) 
Formulation and preparation of matrix tablets 
Drug (Diltiazem Hydrochloride), polymer, lactose, magnesium stearate and talc were passed through 
sieve no. 80 separately. Six different formulations with various  polymer ratios were prepared i.e. 
1:1.25, 1:1.5, 1:1.75, 1:2, 1:2.75 and 1:3 by keeping the amount of lactose at 30 mg and Diltiazem at 
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Table 1.- Composition of Diltiazem hydrochloride matrix tablet. 
Components 
(mg) F1 F2 F3 F4 F5 F6 
Diltiazem 
hydrochloride 90 90 90 90 90 90 
Rosin 112.5 135 157.5 180 247.5 270 
Lactose 30 30 30 30 30 30 
Talc 3% 3% 3% 3% 3% 3% 
Magnesium 
Stearate 2% 2% 2% 2% 2% 2% 
 
Tablet compression 
 The matrix tablets of the above formulations were compressed in a single punch tablet 
compression machine. A weighted amount of the powder was introduced in the die and the die 
capacity was adjusted as required. Compression force was adjusted to obtain the required hardness. A 
batch of 25 tablets was prepared for all formulations. 
Drug-excipient interaction studies 
 Preformulation studies are very important for the successful formulation of any dosage form. 
Differential Scanning Calorimetry (DSC), Fourier Transform Infrared (FTIR) Spectroscopy studies 
(Joshi et al.,) and HPTLC were used for the evaluation of physicochemical compatibility and 
interactions, which  helps in the prediction of interaction of the drug with polymers, diluents and 
lubricants used in case tablet formulations. Positive interactions sometimes have a beneficial effect as 
far as desired release parameters are concerned. The earlier investigations recommended that the ratio 
of drug to excipients used in study was 1:5 for diluents, 3:1 for binders or disintegrants, 5:1 for 
lubricants and 10:1 for colorants etc, but it is observed that 1:1 ratio of drug excipients maximizes the 
possibility of interaction and helps in easier detection of incompatibilities17.  Therefore, in the present 
study 1:1 ratio was used for preparation of physical mixtures and analyzed for compatibility studies. 
Differential scanning calorimetry (DSC) 
 Differential Scanning Calorimetry (DSC) studies was carried out using DSC 60, having TA60 
software, Shimadzu, Japan. The instrument is very versatile as far interaction and compatibility studies 
at pre-formulation stage was concerned and used to evaluate melting point, enthalpy changes and glass 
transition temperatures of drug with excipients and polymers. Diltiazem Hydrochloride was mixed 
with the excipients and the DSC analysis of each sample under the analogous conditions of 
temperature range 40 – 300º C, heating rate 10ºC/min, nitrogen atmosphere (20ml/min) and alumina as 
reference. Differential Scanning Calorimetry (DSC) was performed on pure drug, excipients and 
composition of final formulation. DSC measurements were done on a Shimadzu DSC-60 and samples 
were heated at the rate of 10ºC min-1.The samples were heated in an aluminum cup up to 300ºC.  
Fourier transform infrared (FTIR)  
 FTIR studies are very helpful in the evaluation of drug–polymer interaction studies.  If there is 
any incompatibility between the drugs and excipients, these can be predicted by changes in the 
functional peaks (characteristic wave numbers). Diffuse reflectance technique was used(400 to 4000 
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cm-1), drug and various polymers  were  thoroughly mixed with 300mg of potassium bromide, 
compressed and the spectrum was obtained by placing the thin pellet in light path. 
HPTLC technique18 
 TLC technique is a non thermal technique very helpful in the evaluation of drug polymer 
interaction studies. If there is any interaction between the drug and excipients, there can be determined 
by change in the Rf value. High performance thin layer chromatography (HPTLC) chromatogram 
data’s were taken on a CAMAG instrument to find out the incompatibility of the drug with excipients 
used in the formulation. HPTLC chromatogram of the drug and composition of final formulation were 
obtained by using the composition of acetic acid : water : methylene chloride : ethanol (1 : 3 : 10 : 12, 
v/v) as mobile phase on precoated silica gel F254 plates used as stationary phase.  
Evaluation of tablet formulations19 
Evaluation of characteristics of powder blend and tablets  
 The various characteristics of powder blend like bulk density, tapped density, angle of repose, 
particle size and drug content were studied. The formulated tablets were evaluated for hardness, 
friability, uniformity of weight and drug content.  
Drug content of formulated tablets  
 Five tablets from each formulation were randomly chosen, pulverized and weight equivalent 
to 50mg of Diltiazem Hydrochloride was extracted with 100ml phosphate buffer (pH 7.4). Aliquot 
from subsequent filtered solution was further diluted in phosphate buffer (pH 7.4) in such a way that 
theoretical concentration was same as that of standard concentration. Resultant solutions were 
analyzed by using a UV spectrophotometer (in triplicate) and the average results taken. 
In vitro dissolution studies 
 The dissolution studies were performed in triplicate for all the batches in a USP XXIII 
dissolution rate test apparatus (type II).  The release studies were performed at 75 rpm in 900 ml of 
phosphate buffer pH 7.4 at 37 ± 0.2οC. Five milliliters aliquots were withdrawn at predefined 
intervals, and the volume of the dissolution medium was maintained by adding the same volume of 
fresh prewarmed dissolution medium. The absorbance of the withdrawn samples was measured 
spectrophotometrically at 237 nm.  
Data analysis 
 Different release kinetics is assumed to reflect different release kinetics mechanism. Therefore 
three kinetics models including zero order release equation (Eq.1), first order equation (Eq. 2) and 
Higuchi (Eq .3) were applied to process in vitro data to find the equation with the best fit. 
Q = K1t       (Eq .1) 
Q = 100 (1-e-K2t)  (Eq. 2) 
Q = K3 (t) 0.5    (Eq. 3) 
Where Q is the release percentage at time t. K1, K2 and K3 are the rate constant of zero order, first 
order and Higuchi model respectively.               
RESULTS AND DISCUSSION 
 In the present study an attempt has been made to formulate matrix tablets of Diltiazem HCl 
using rosin as hydrophobic matrix material. 
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 Drug excipient compatibility studies were carried out to check whether any compatibility 
related problems are associated between drug and excipients used in the formulations. DSC results 
revealed that the physical mixture of Diltiazem with excipients showed superimposition of the 
thermograms. There is no considerable change observed in melting endotherm.  The DSC 
thermograms are shown in Figure 1. Diltiazem Hydrochloride contains two carbonyl groups, shows 
the values around 1679 and 1745 cm-1. Infrared studies reveal that both characteristic bands around 
1679 and 1745 cm-1 were present in all spectra. While no new bands or shift in characteristic peaks 
appeared.  IR spectra are shown in Figure 2. In HPTLC technique, Rf value for the drug was around 
0.74. HPTLC studies revealed that the Rf values obtained for the drug and excipient mixture were 
around 0.74.  HPTLC chromatograms are shown in Figure 3, 4 and 5. DSC, FTIR and HPTLC results 
revealed that there is no interaction between the drug and the excipients used in the formulation.  
Figure 1.- DSC thermograms. 
 
1. DSC thermogram of diltiazem hydrochloride 
2. DSC thermogram of diltiazem hydrochloride : lactose (1:1) 
3. DSC thermogram of diltiazem hydrochloride: magnesium stearate (1:1) 
4. DSC thermogram of diltiazem hydrochloride: talc (1:1) 
5. DSC thermogram of diltiazem hydrochloride: rosin (1:1) 
 
The pre compression parameters like bulk density and compressibility index reveal that the powder 
mixture had good flow properties, the results are shown in Table 2. Post compression parameters for 
all formulations are shown in Table 3. All the tablets were found to pass the uniformity of weight. 
Content of Diltiazem HCl from all formulations was found in the range of 98.5 to 101.0%.  
The hardness of tablets from all formulations was between 4 and 5 kg/cm2. All the formulations 
showed friability between 0.55 and 0.85% indicating that the tablets could withstand the mechanical 
shock. The performance of sustained release formulation has been reported to be greatly affected by 
physicochemical properties of polymer. Six different combination of polymer: drug was used to 
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prepare the sustained release matrix tablets. It was observed that the amount of polymer influences the 
drug release.  In vitro release study results revealed that the release of drug was retarded with the 
proportional increase of the polymer concentration.  Release results are shown in Figure 6.  98.0% 
release was observed in 12 h for the ratio of 1:1.25, in 16 h for 1:1.5 and in 24 h for 1:1.75 (Drug: 
Polymer). 1:1.75 (drug: polymer) ratio showed 98.0% release in 24 h, which was comparable to 
market formulation of Diltiazem Hydrochloride. Release results are shown in Figure 7. Beyond this 
ratio 1:1.75,  release of drug was retarded this may be due to the hydrophobic nature of the polymer, 
which prevents the penetration of the dissolution medium into the matrix tablets leading to slower 
dissolution and diffusion of the drug molecules from the matrix system. 
Figure 2.-  IR spectra of drug and physical mixtures. 
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The optimized formulation was then subjected to check the effect of release enhancers like lactose, 
MCC, DCP and Mannitol. The composition is shown in Table 4, and it was subjected to in vitro 
release studies. The control of these factors can be successfully used to modulate the release rate from 
matrices to show the effect of water soluble and water insoluble diluents.  Comparative release results 
are shown in Figure 8. From the release profile the tablets containing MCC as diluent showed 
significant increase in the release of drug, this might be due to its swelling behavior of MCC in water 
and eventually disintegration of the tablets. Tablets contain mannitol and lactose as diluent showed 
significant higher drug release when compared with MCC and DCP. These might be due the rapid 
solubility of lactose and mannitol, tendency to form pores in the matrix which allow the dissolution 
medium to penetrate the matrix and dissolve the drug.  These results may explain the slower release 
from rosin matrices containing MCC and DCP compared to those containing lactose or mannitol. 
 
Table  3.- Post compression parameters of the formulated tablets. 
Parameters Values Permissible limits 
Thickness (mm) 2.58 ± 0.34 --- 
Weight variation 3.42 ± 0.43 < 5.0% 
Hardness 4.4 ± 0.32 3.0 – 6.0 kg/cm2
Friability 0.66 ± 0.12 0.5 – 1.0 % 
Drug content 98.92 ± 0.28 95.0 – 105.0 % w/w 
Content uniformity 98.53 ± 0.54 95.0 – 105.0 % w/w 
 
 
Table 4.- Composition of diltiazem hydrochloride matrix tablet with different diluent. 
Ingredients(mg) F7(1:1.75) F8(1:1.75) F9(1:1.75) F10(1:1.75) 
Diltiazem 
Hydrochloride 90 90 90 90 
Rosin 157.5 157.5 157.5 157.5 
Lactose.H2O 30 - - - 
Micro crystalline 
cellulose - 30 - - 
Dicalcium 
Phosphate - - 30 - 
Mannitol - - - 30 
Magnesium 
Stearate 2% 2% 2% 2% 
Talc 3% 3% 3% 3% 
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Figure 3.- HPTLC chromatogram of diltiazem hydrochloride. 
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Figure 5.- HPTLC chromatogram of matrix tablet formulation. 
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 The study showed that rosin is an appropriate hydrophobic material that can be utilized as 
matrix forming agent to prolong the release of water soluble drug such as Dilitiazem HCl. Preparation 
of matrices by direct compression was found to be more effective in controlling the release of drug. 
Release of drug from the matrices can be adjusted by using release enhancers like Lactose, Mannitol, 
MCC and DCP. Rosin is widely available in India, and is inexpensive. It can be used as substitute in 
place of currently marketed matrix forming polymers. The drug release from all the formulations 
mentioned above followed first order kinetics and the Higuchi model, thus indicating that there was no 
erosion of the matrix and the tablet maintained its surface area and shape. 
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